These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6117334)

  • 1. An effect of neuroleptic medication on plasma dopamine-beta-hydroxylase activity.
    DeLisi LE; Phelps BH; Wise CD; Apostoles PS; Bigelow L; Wyatt RJ
    Biol Psychiatry; 1981 Sep; 16(9):873-8. PubMed ID: 6117334
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia.
    Goodnick PJ; Tong C; Duncavage MB; Meltzer HY
    Biol Psychiatry; 1983 Dec; 18(12):1485-8. PubMed ID: 6140962
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum dopamine-beta-hydroxylase activity in schizophrenia.
    Meltzer HY; Nasr SJ; Tong C
    Biol Psychiatry; 1980 Oct; 15(5):781-8. PubMed ID: 6106516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Neuropsychobiology; 1982; 8(6):312-4. PubMed ID: 6131392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical studies on tardive dyskinesia. II. Urinary methoxyhydroxyphenylglycol and plasma dopamine-beta-hydroxylase.
    Markianos M; Tripodianakis J; Garelis E
    Biol Psychiatry; 1983 Mar; 18(3):347-54. PubMed ID: 6132626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma dopamine beta hydroxylase activity in chronic schizophrenic patients tested with single dose of 2-bromo-alpha ergocriptine (Parlodel).
    Vardi J; Flechter S; Oberman Z; Segal R; Shogan G; Haker O
    Encephale; 1981; 7(1):95-103. PubMed ID: 7227288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma copper and dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Perlman R; Levitt M; Meltzer H; Gruen R; Asnis L
    Biol Psychiatry; 1982 Jan; 17(1):115-20. PubMed ID: 7059633
    [No Abstract]   [Full Text] [Related]  

  • 8. [A study of plasma dopamine-beta-hydroxylase activity in patients with schizophrenia].
    Kuang PG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Nov; 15(4):193-7. PubMed ID: 7183426
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity.
    Baron M; Levitt M; Asnis L; Fein M
    Biol Psychiatry; 1983 May; 18(5):579-82. PubMed ID: 6860731
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenia.
    Arató M; Bagdy G; Perényi A
    Biol Psychiatry; 1982 Jul; 17(7):853-4. PubMed ID: 6126229
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical markers in the study of clinical effects and extrapyramidal side effects of neuroleptics.
    Perényi A; Bagdy G; Arató M; Frecska E
    Psychiatry Res; 1984 Oct; 13(2):119-27. PubMed ID: 6151713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenia: dopamine beta-hydroxylase activity and treatment response.
    Sternberg DE; VanKammen DP; Lerner P; Bunney WE
    Science; 1982 Jun; 216(4553):1423-5. PubMed ID: 6124036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of the antipsychotic effect in schizophrenia and some changes in postmortem brain and their relation to neuroleptic medication.
    Crow TJ; Cross AJ; Johnstone EC; Longden A; Owen F; Ridley RM
    Adv Biochem Psychopharmacol; 1980; 24():495-503. PubMed ID: 6105795
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma DBH activity: relation to genetic factors in schizophrenia.
    Baron M; Levitt M; Perlman R
    Commun Psychopharmacol; 1980; 4(3):197-202. PubMed ID: 7226750
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic drugs and erythrocyte catechol-O-methyltransferase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Biol Psychiatry; 1982 Nov; 17(11):1339-42. PubMed ID: 6129906
    [No Abstract]   [Full Text] [Related]  

  • 17. Low plasma dopamine-beta-hydroxylase in demented schizophrenics.
    Markianos M; Tripodianakis J
    Biol Psychiatry; 1985 Jan; 20(1):98-101. PubMed ID: 3965042
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum dopamine-beta-hydroxylase activity and lateral ventricular size in affective disorders and schizophrenia.
    Meltzer HY; Tong C; Luchins DJ
    Biol Psychiatry; 1984 Oct; 19(10):1395-402. PubMed ID: 6335052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma dopamine- -hydroxylase activity in hypertension and various neuropsychiatric disorders.
    Wetterberg L; Aberg H; Ross SB; Frödén O
    Scand J Clin Lab Invest; 1972 Nov; 30(3):283-9. PubMed ID: 4264461
    [No Abstract]   [Full Text] [Related]  

  • 20. CSF dopamine beta-hydroxylase in schizophrenia.
    Sternberg DE; van Kammen DP; Lerner P; Ballenger JC; Marder SR; Post RM; Bunney WE
    Arch Gen Psychiatry; 1983 Jul; 40(7):743-7. PubMed ID: 6134515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.